Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
9.63B
Market cap9.63B
Price-Earnings ratio
256.34
Price-Earnings ratio256.34
Dividend yield
Dividend yield
Average volume
1.08M
Average volume1.08M
High today
High today
Low today
Low today
Open price
$89.69
Open price$89.69
Volume
0.00
Volume0.00
52 Week high
$95.11
52 Week high$95.11
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

The current Corcept Therapeutics(CORT) stock price is $89.72, with a market capitalization of 9.63B. The stock trades at a price-to-earnings (P/E) ratio of 256.34.

On 2026-07-17, Corcept Therapeutics(CORT) shares started trading at $89.69, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.08M.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $95.11 and a low of $28.66.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $95.11 and a low of $28.66.

CORT News

Nasdaq 5d
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook

Key Points The transaction realized $1.9 million in gross proceeds on July 7, 2026, at a weighted average price of $93.13 per share. The disposition was a cas...

Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.